Arcutis Biotherapeutics Reports Inducement Grants
Arcutis Biotherapeutics announced the grant of an aggregate of 62,500 restricted stock units (RSUs) under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Arcutis Biotherapeutics reports inducement grants
Arcutis Biotherapeutics said it granted inducement awards under Nasdaq Listing Rule 5635(c)(4).
ARQT reports inducement grants under Nasdaq Rule 5635(c)(4)
Arcutis Biotherapeutics (ARQT) reported inducement grants under Nasdaq Listing Rule 5635(c)(4).